spacer
home > white papers > Sterile Vials Made of Tubular Glass - Gerresheimer AG
WHITE PAPERS
logo_Gerresheim1.jpg

Gerresheimer AG

phone +49-(0)211/61 81-00
email info@gerresheimer.com
web http://www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany

Sterile Vials Made of Tubular Glass

Gx® RTF vials powered by Ompi EZ-fill® enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and ready-to-fill processing for our pharma and biotech customers.
Sterile Vials Made of Tubular Glass
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Our responsibility: employee health and taking care of patients needs

Düsseldorf, March 24, 2020. We as Gerresheimer face up to the special situation in view of the corona virus which is spreading worldwide. We are aware of our role as a key supplier of medicines and supplies for everyday life.
More info >>


White Papers

Risk-Based Inspection Readiness: Reducing Headaches with Advanced Preparation

The Avoca Group

So often, inspections are a major source of stress in the clinical trial environment. This is especially true when processes involved in preparing for an inspection are reactive. But, it doesn’t have to be that way. Using industry-leading practices and resources enables a proactive approach to mitigate—or even eliminate—the pain points associated with preparing for inspections.
More info >>


Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement